([2-(Bis-carboxymethyl-amino)-ethyl]-{[2-(5-sulfamoyl-[1,3,4]thiadiazol-2-ylcarbamoyl)-ethylcarbamoyl]-methyl}-amino)-acetic acid

InChIKey	`XKHSVUSPZVNCOT-UHFFFAOYSA-N`
Compound Name	([2-(Bis-carboxymethyl-amino)-ethyl]-{[2-(5-sulfamoyl-[1,3,4]thiadiazol-2-ylcarbamoyl)-ethylcarbamoyl]-methyl}-amino)-acetic acid
Canonical SMILES	`NS(=O)(=O)c1nnc(NC(=O)CCNC(=O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)s1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	8.03
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P00918	CA2	Homo sapiens	Human	PF00194	8.7	Ki	ChEMBL;BindingDB
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	8.7	pIC50	TTD_MultiTarget
P00915	CA1	Homo sapiens	Human	PF00194	6.7	Ki	ChEMBL;BindingDB